Lenalidomide overcomes the resistance to third-generation CD19-CAR-T cell therapy in preclinical models of diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lenalidomide overcomes the resistance to third-generation CD19-CAR-T cell therapy in preclinical models of diffuse large B-cell lymphoma

Published:2023-05-23 Issue:4 Volume:46 Page:1143-1157
ISSN:2211-3428
Container-title:Cellular Oncology
language:en
Short-container-title:Cell Oncol.

Author:

Jin Zhen,Xiang Rufang,Qing Kai,Li Dan,Liu Zhao,Li Xiaoyang,Zhu Hongming,Zhang Yunxiang,Wang Lining,Xue Kai,Liu Han,Xu Zizhen,Wang Yingxiao,Li Junmin

Funder

National Natural Sciences Foundation of China

the Shanghai Sailing Program; the Science and Technology Commission of the Shanghai Municipality

the National Key R&D Program

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Medicine,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s13402-023-00833-6.pdf

Reference56 articles.

1. J.S. Abramson, Trans Med Rev 34, 29–33 (2020). https://doi.org/10.1016/j.tmrv.2019.08.003

2. E. Jacoby, S.A. Shahani, N.N. Shah, Immunol Rev 290, 39–59 (2019). https://doi.org/10.1111/imr.12774

3. R. Gardner, D. Wu, S. Cherian, M. Fang, L.A. Hanafi, O. Finney, H. Smithers, M.C. Jensen, S.R. Riddell, D.G. Maloney, C.J. Turtle, Blood 127, 2406–2410 (2016). https://doi.org/10.1182/blood-2015-08-665547

4. T.J. Fry, N.N. Shah, R.J. Orentas, M. Stetler-Stevenson, C.M. Yuan, S. Ramakrishna, P. Wolters, S. Martin, C. Delbrook, B. Yates, H. Shalabi, T.J. Fountaine, J.F. Shern, R.G. Majzner, D.F. Stroncek, M. Sabatino, Y. Feng, D.S. Dimitrov, L. Zhang, S. Nguyen, H. Qin, B. Dropulic, D.W. Lee, C.L. Mackall, Nat Med 24, 20–28 (2018). https://doi.org/10.1038/nm.4441

5. S.S. Neelapu, F.L. Locke, N.L. Bartlett, L.J. Lekakis, D.B. Miklos, C.A. Jacobson, I. Braunschweig, O.O. Oluwole, T. Siddiqi, Y. Lin, J.M. Timmerman, P.J. Stiff, J.W. Friedberg, I.W. Flinn, A. Goy, B.T. Hill, M.R. Smith, A. Deol, U. Farooq, P. McSweeney, J. Munoz, I. Avivi, J.E. Castro, J.R. Westin, J.C. Chavez, A. Ghobadi, K.V. Komanduri, R. Levy, E.D. Jacobsen, T.E. Witzig, P. Reagan, A. Bot, J. Rossi, L. Navale, Y. Jiang, J. Aycock, M. Elias, D. Chang, J. Wiezorek, W.Y. Go, New Engl J Med 377, 2531–2544 (2017). https://doi.org/10.1056/NEJMoa1707447

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy;Molecular Cancer;2024-08-26

2. Immunomodulatory drugs: a promising clinical ally for cancer immunotherapy;Trends in Molecular Medicine;2024-08

3. CAR-T cell combination therapies in hematologic malignancies;Experimental Hematology & Oncology;2024-07-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3